[Effect of dobutamine and diltiazem on the reperfused ischemic myocardium]. 1987

N Oshima

Twenty-two anesthetized open-chest mongrel dogs were studied to evaluate the effect of dobutamine, dobutamine and diltiazem on the ischemic-reperfused myocardium assessed by cardiac function, myocardial metabolism such as tissue ATP, Ca and water content and ultrastructure. The left anterior descending coronary artery was ligated for 40 minutes and then reperfused for 15 minutes. Experiments were divided into 3 groups by infusion of physical saline solution (C), dobutamine 5 micrograms/kg/m in (DOB) and dobutamine 5 micrograms/kg/min+diltiazem 0.1mg/kg bolus IV at the beginning of reperfusion and followed by continuous infusion with 30 micrograms/kg/min (DOB+D) during reperfusion period. DOB increased SAP and CI, however it also increased heart rate. CI, LVSWI and coronary blood flow in non ischemic area increased significantly in DOB+D than either C or DOB. Myocardial ATP in the ischemic endocardium was much more preserved in DOB and DOB+D than C. Myocardial Ca and water content were lower level in DOB+D, but not significantly different among 3 groups. Mitochondrial score by Sunamori's method in DOB+D was higher than that in C (p less than 0.05). These results suggest that low dose of dobutamine during reperfusion is effective to enhance hemodynamic parameters without deterioration of myocardial metabolism, and furthermore combined use of dobutamine and diltiazem is more effective to protect myocardial metabolism and ultrastructure from reperfusion damage in addition to improvement of hemodynamic parameters.

UI MeSH Term Description Entries
D010477 Perfusion Treatment process involving the injection of fluid into an organ or tissue. Perfusions
D003326 Coronary Circulation The circulation of blood through the CORONARY VESSELS of the HEART. Circulation, Coronary
D003327 Coronary Disease An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels. Coronary Heart Disease,Coronary Diseases,Coronary Heart Diseases,Disease, Coronary,Disease, Coronary Heart,Diseases, Coronary,Diseases, Coronary Heart,Heart Disease, Coronary,Heart Diseases, Coronary
D004110 Diltiazem A benzothiazepine derivative with vasodilating action due to its antagonism of the actions of CALCIUM ion on membrane functions. Aldizem,CRD-401,Cardil,Cardizem,Dilacor,Dilacor XR,Dilren,Diltiazem Hydrochloride,Diltiazem Malate,Dilzem,Tiazac,CRD 401,CRD401
D004280 Dobutamine A catecholamine derivative with specificity for BETA-1 ADRENERGIC RECEPTORS. It is commonly used as a cardiotonic agent after CARDIAC SURGERY and during DOBUTAMINE STRESS ECHOCARDIOGRAPHY. Dobucor,Dobuject,Dobutamin Fresenius,Dobutamin Hexal,Dobutamin Solvay,Dobutamin-ratiopharm,Dobutamina Inibsa,Dobutamina Rovi,Dobutamine (+)-Isomer,Dobutamine Hydrobromide,Dobutamine Hydrochloride,Dobutamine Lactobionate,Dobutamine Phosphate (1:1) Salt, (-)-Isomer,Dobutamine Tartrate,Dobutamine Tartrate (1:1), (R-(R*,R*))-Isomer,Dobutamine Tartrate (1:1), (S-(R*,R*))-Isomer,Dobutamine, (-)-Isomer,Dobutamine, Phosphate (1:1) Salt (+)-Isomer,Dobutrex,Lilly 81929,Oxiken,Posiject,Dobutamin ratiopharm,Hydrobromide, Dobutamine,Hydrochloride, Dobutamine,Lactobionate, Dobutamine,Tartrate, Dobutamine
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog
D006321 Heart The hollow, muscular organ that maintains the circulation of the blood. Hearts
D006439 Hemodynamics The movement and the forces involved in the movement of the blood through the CARDIOVASCULAR SYSTEM. Hemodynamic
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

N Oshima
October 1986, Journal of the American College of Cardiology,
N Oshima
April 1989, The Journal of pharmacology and experimental therapeutics,
N Oshima
January 1982, Journal of cardiovascular pharmacology,
N Oshima
January 1993, Japanese circulation journal,
N Oshima
October 1980, Journal of molecular and cellular cardiology,
N Oshima
November 2001, Perfusion,
N Oshima
November 1982, Rinsho kyobu geka = Japanese annals of thoracic surgery,
N Oshima
April 1988, Rinsho kyobu geka = Japanese annals of thoracic surgery,
N Oshima
June 1984, European journal of pharmacology,
N Oshima
March 1992, The Journal of pharmacology and experimental therapeutics,
Copied contents to your clipboard!